XML 17 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock and additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Balance, beginning balance at Dec. 31, 2015 $ 167,498 $ 59,970 $ 106,673 $ 855
Balance, beginning period (in shares) at Dec. 31, 2015   10,753,855    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 4,503   4,503  
Net unrealized gain on securities available for sale, net of tax 1,852     1,852
Net unrealized loss on securities transferred from available for sale to held to maturity, net of tax (11)     (11)
Comprehensive income 6,344   4,503 1,841
Cash dividends declared (2,370)   (2,370)  
Equity compensation expense 49 $ 49    
Payment to repurchase common stock (129)   (129)  
Payment to repurchase of common stock (in shares)   (6,936)    
Tax benefit from vesting of restricted stock 32 $ 32    
Issuance of restricted stock (in shares)   21,847    
Proceeds from sale of common stock 121 $ 121    
Proceeds from sale of common stock (in shares)   6,541    
Balance, ending period at Mar. 31, 2016 $ 171,545 $ 60,172 108,677 2,696
Balance, ending balance (in shares) at Mar. 31, 2016 10,775,307 10,775,307    
Balance, beginning balance at Dec. 31, 2016 $ 172,521 $ 60,831 111,693 (3)
Balance, beginning period (in shares) at Dec. 31, 2016 10,793,946 10,793,946    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income $ 4,637   4,637  
Net unrealized gain on securities available for sale, net of tax 1     1
Net unrealized gain on cash flow hedging derivative instruments 63     63
Net unrealized loss on securities transferred from available for sale to held to maturity, net of tax (4)     (4)
Comprehensive income 4,697   4,637 60
Cash dividends declared (2,487)   (2,487)  
Equity compensation expense 83 $ 83    
Payment to repurchase common stock (146)   (146)  
Payment to repurchase of common stock (in shares)   (5,258)    
Issuance of restricted stock (in shares)   18,850    
Proceeds from sale of common stock 185 $ 185    
Proceeds from sale of common stock (in shares)   6,594    
Balance, ending period at Mar. 31, 2017 $ 174,853 $ 61,099 $ 113,697 $ 57
Balance, ending balance (in shares) at Mar. 31, 2017 10,814,132 10,814,132